11 September 2025
HTA for biologics for non-SJIA

11 September 2025
HTA for biologics for non-SJIA
About Project
Content
Conducting economic evaluation and budget impact of biologic agents as 2nd-line treatment options for non-systemic juvenile idiopathic arthritis patients who are refractory to 1st-line treatment.
Documents
Research Type
Others
Related Technologies
Health Policies
Pharmaceuticals
Others
Research Team
Principal Researcher